Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics World Congress 2013

Norman Nelson's Biography



Norman Nelson, Senior Consultant, NCN Enterprises

Dr. Nelson received his BS in Chemistry from The California Institute of Technology in 1976 and his PhD in Chemistry from the University of California at San Diego in 1982. He joined Gen-Probe (a leading molecular diagnostics company) in 1985, where over his 27 year tenure held positions of increasing responsibility, culminating in the role of Senior Director of Discovery Research. Dr. Nelson has extensive experience in the development of technology for FDA-regulated molecular diagnostic products. He is also an expert in Next Generation Sequencing, including direct experience with Illumina, Ion Torrent & Pacific Biosciences platforms. He also has a proven track record in innovation, as well as the associated reduction to practice and implementation. As an inventor or co-inventor on 26 issued U.S. patents, and more than 100 issued and pending patents world-wide, he played a key role in the commercialization of multiple technologies, many of which are core to Gen-Probe products that generate >$500MM in annual revenue. He also has broad expertise and experience in intellectual property protection. Dr. Nelson now owns his own consulting business, NCN Enterprises.

Norman Nelson Image

Selector, A New MDx Assay Format for the Sensitive Detection of Rare Targets

Thursday, 12 September 2013 at 08:15

Add to Calendar ▼2013-09-12 08:15:002013-09-12 09:15:00Europe/LondonSelector, A New MDx Assay Format for the Sensitive Detection of Rare TargetsPoint-of-Care Diagnostics World Congress 2013 in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com

A new molecular diagnostic assay has been developed for the detection of rare genetic alterations, minority species and other rare targets present in complex wild-type genomic backgrounds.  The assay can be configured to detect single mutations or groups of mutations, displays exquisite sensitivity and can detect mutations at less than 0.01% prevalence.


Add to Calendar ▼2013-09-12 00:00:002013-09-13 00:00:00Europe/LondonPoint-of-Care Diagnostics World Congress 2013Point-of-Care Diagnostics World Congress 2013 in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com